Topline Data from Phase 3 clinical trial of cefepime-taniborbactam in patients with complicated urinary tract infections (cUTIs) expected first quarter 2022 BARDA extends cost-sharing contract to ...
November 4, 2009 (Philadelphia, Pennsylvania) — Despite concerns raised after a meta-analysis suggested that increased mortality is associated with cefepime use in patients with febrile neutropenia ...
MALVERN, Pa. and FLORENCE, Italy, Jan. 9, 2024 /PRNewswire/ -- Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with ...
June 26, 2012 – The US Food and Drug Administration (FDA) is reminding healthcare professionals about the need to adjust the dosage of the antibacterial drug cefepime in patients with renal impairment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback